| Matthew S Mccoy, MD | |
|
1615 Delaware St, Longview, WA 98632-2310 | |
| (360) 414-2000 | |
| Not Available |
| Full Name | Matthew S Mccoy |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1615 Delaware St, Longview, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851332886 | NPI | - | NPPES |
| 8360844 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD00042258 (Washington) | Primary |
| Entity Name | Kaiser Foundation Health Plan Of The Northwest |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040220000099 |
News Archive
Boston Scientific Corporation's ION Paclitaxel-Eluting Platinum Chromium Coronary Stent System and TAXUS Liberte Paclitaxel-Eluting Coronary Stent System have received U.S. Food and Drug Administration (FDA) approval for use in patients experiencing an acute myocardial infarction (AMI), or heart attack.
Chemists at the University of Texas at Arlington have published a new study that indicates that highly variable contamination events registered in and around unconventional oil and gas developments are the result of operational inefficiencies and not inherent to the extraction process itself.
Next time you're doing a slow burn in security screening at the airport, calm yourself with the assurance that a more deliberate baggage scanner may do a better job.
Current asthma treatments can alleviate wheezing, coughing and other symptoms felt by millions of Americans every year, but they don't get to the root cause of the condition. Now, for the first time, scientists are reporting a new approach to defeating asthma by targeting the trigger - the allergen - before it can spark an attack. They describe their new compound, which they tested on rats, in ACS' Journal of Medicinal Chemistry.
California Stem Cell, Inc. (CSC), a leading stem cell company, announced that it has completed a Series B financing round with private investors. The financing will enable the company to support the advancement of its therapeutic products to human clinical trials, as well as the generation and distribution of its tools to aid in stem cell research and drug discovery.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew S Mccoy, MD Po Box 11510, Westminster, CA 92685-1510 Ph: () - | Matthew S Mccoy, MD 1615 Delaware St, Longview, WA 98632-2310 Ph: (360) 414-2000 |
News Archive
Boston Scientific Corporation's ION Paclitaxel-Eluting Platinum Chromium Coronary Stent System and TAXUS Liberte Paclitaxel-Eluting Coronary Stent System have received U.S. Food and Drug Administration (FDA) approval for use in patients experiencing an acute myocardial infarction (AMI), or heart attack.
Chemists at the University of Texas at Arlington have published a new study that indicates that highly variable contamination events registered in and around unconventional oil and gas developments are the result of operational inefficiencies and not inherent to the extraction process itself.
Next time you're doing a slow burn in security screening at the airport, calm yourself with the assurance that a more deliberate baggage scanner may do a better job.
Current asthma treatments can alleviate wheezing, coughing and other symptoms felt by millions of Americans every year, but they don't get to the root cause of the condition. Now, for the first time, scientists are reporting a new approach to defeating asthma by targeting the trigger - the allergen - before it can spark an attack. They describe their new compound, which they tested on rats, in ACS' Journal of Medicinal Chemistry.
California Stem Cell, Inc. (CSC), a leading stem cell company, announced that it has completed a Series B financing round with private investors. The financing will enable the company to support the advancement of its therapeutic products to human clinical trials, as well as the generation and distribution of its tools to aid in stem cell research and drug discovery.
› Verified 3 days ago
John Y Kim, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 360-636-4831 | |
Brian Hoyt, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 360-414-2000 | |
Dr. Ryan Michael Caulfield, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 360-636-4830 | |
Dr. Rusty Wes Gust, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 360-414-2000 | |
Aftab A Awan, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 360-414-2730 Fax: 360-414-2739 | |
Paul A Schneider, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 360-414-2000 | |
Gary Elliot Penner, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 360-414-2000 |